Choose the stock you wish to monitor with a price target
Recently Viewed
C
CME Group Inc
DUS:MX4A
US
N
NOVA Technology Corp Ltd
SZSE:300921
CN
P
Premier Miton Group PLC
OTC:PASMF
UK
E
Exicon Co Ltd
KOSDAQ:092870
KR
S
SC Estate Builder Bhd
KLSE:SCBUILD
MY
1
1847 Holdings LLC
AMEX:EFSH
US
K
Kendrion NV
SWB:K3E
NL
Aisin Corp
F:AKN
JP
Sinopharm Group Co Ltd
F:X2S1
CN
Back to Note
Company Overview
Business Description
Sector
Financials
Industry
Financial Services
Headquarters
United States of AmericaUS
Employees
3 875
IPO date
Dec 6, 2002
CME Group runs one of the world’s largest marketplaces for exchange-traded derivatives. It matches buyers and sellers in contracts tied to interest rates, stock indexes, foreign currencies, energy, metals, and agricultural products. Instead of making the underlying goods itself, the company provides the exchange, clearing, and risk-management infrastructure that lets banks, asset managers, corporations, and other traders hedge price moves or take positions on them.
The company makes money mainly by charging transaction and clearing fees when those contracts are traded or settled, along with fees for market data and related services. Its customers are the financial firms, hedge funds, trading firms, commercial businesses, and institutions that use futures and options to manage risk or gain exposure to markets. Because these contracts are standardized and centrally cleared, CME sits at the center of the trading process and helps make these markets easier to use and safer to trade.
What makes CME’s business different is that it acts as the market organizer and counterparty manager, not a product manufacturer or broker. Once a contract is listed, it can attract more trading from both hedgers and speculators, which helps make the exchange more useful to all participants. That network role, plus the importance of clearing and risk control, gives CME a central place in the global derivatives market.
Business Segments is available only for users with
Unlimited Plan
Unlock
Business Segments
Derivatives trading and clearing
CME Group runs exchanges and clearing houses where customers trade and settle futures and options on interest rates, stock indexes, currencies, energy, metals, and farm goods. It also provides market data and electronic...
Customers
Banks, asset managers, hedge funds, commodity firms, traders, and companies that use derivatives to hedge price and rate risk.
Revenue Model
It earns money from trading fees, clearing fees, market data subscriptions, and connectivity and technology service charges.
Management
Mr. Sunil Cutinho
Chief Information Officer
Sunil Cutinho serves as the President of CME Clearing, a division of CME Group Inc. In this role, he is responsible for overseeing the risk management and clearing functions, ensuring the safeguarding and management of collateral as well as guaranteeing the integrity and financial stability of the marketplace. His leadership is critical in managing counterparty risk and protecting market participants in CME Group's clearing operations.
Before assuming the President position, Cutinho held several other roles at CME Group, where he contributed significantly to technological and clearing services advancements. His background includes extensive experience in technology and operations within financial services, having led the transformation and innovation in risk management and settlement processes.
Cutinho's leadership and expertise have been vital in guiding CME Clearing through changes in regulatory landscapes and in adapting to the evolving needs of the market. His work ensures that the clearing operations remain efficient, reliable, and secure, providing the foundation for one of the world's leading derivatives marketplaces.
Mr. Derek Sammann
Senior MD & Global Head of Commodities Markets
Derek Sammann is a prominent figure in the global derivatives market, known for his role at CME Group Inc., where he has made significant contributions. At CME Group, Derek Sammann serves as the Senior Managing Director and Global Head of Commodities, Options, and International Markets. In this capacity, he is responsible for the strategic leadership and growth of CME Group's options and commodity product lines, as well as the company's international business development efforts.
Derek Sammann joined CME Group in 2006, bringing with him extensive experience in the industry, having held various leadership positions focused on trading, risk management, and the expansion of global markets. His unique expertise has been instrumental in driving innovation and expansion within the CME Group's diverse portfolio of products.
Under his leadership, the company has seen significant advancements in the trading of options and commodities, bolstering CME Group's position as a leader in the global derivatives marketplace. Sammann's vision and strategic direction have also been pivotal in fostering international relationships and expanding CME Group's footprint in key global markets.
His work is characterized by a deep understanding of the complexities of derivatives trading and a commitment to advancing CME Group's reach and influence across the globe. Derek Sammann is recognized for his strategic insight, leadership, and dedication to the growth and development of CME Group within the international financial landscape.
Mr. Michael G. Dennis
Global Head of Fixed Income
Michael G. Dennis serves as the Managing Director and Chief Corporate Development Officer at CME Group Inc. In this capacity, he plays a pivotal role in shaping the strategic direction of the company. His responsibilities primarily include leading mergers, acquisitions, and other strategic initiatives that are essential for the growth and expansion of CME Group in the global financial markets. Dennis is instrumental in identifying new opportunities and partnerships that align with the company's long-term objectives.
With an extensive background in corporate development, Dennis has been a key figure in executing transformative transactions that enhance the company’s competitive position. Prior to his current role, he gained considerable experience in investment banking and financial services, which equipped him with the skills necessary to navigate the complex financial landscape. He is recognized for his strategic vision, leadership, and ability to drive value creation for the organization.
Michael G. Dennis's contributions continue to be significant as he guides CME Group through evolving market dynamics and positions the company for sustained success in the industry.
Ms. Suzanne Sprague
Senior MD, COO & Global Head of Clearing
Suzanne Sprague is a notable executive at CME Group Inc., where she plays an important role in the company’s operations within its clearing and risk management functions. Generally, her responsibilities at CME Group may include overseeing the development and implementation of risk management strategies, ensuring the integrity and security of financial transactions processed through the exchange, and contributing to the strategic initiatives of the company.
Her leadership and expertise in risk management and clearing services have been instrumental in maintaining CME Group's reputation as a leading global derivatives marketplace. Ms. Sprague's work supports the seamless functioning of futures and options trading, ensuring a robust framework for risk assessment and mitigation.
Suzanne Sprague's contributions to the company have likely involved collaboration with regulatory bodies, continuous enhancement of risk management tools, and possibly innovations that drive growth and operational efficiency. Her role underscores CME Group's commitment to providing secure and reliable financial markets.
Mr. Jack Tobin
MD & Chief Accounting Officer
Jack Tobin serves as the Managing Director and Chief Executive Officer of CME Ventures, a subsidiary of the CME Group. In this role, he is responsible for overseeing venture capital investments and strategic initiatives. His work involves identifying innovative technologies and startups that align with the broader goals of the CME Group, which is a leading global derivatives marketplace.
Tobin has a strong background in financial services and technology, contributing to his effective leadership at CME Ventures. His experiences and leadership skills play a significant role in guiding the strategic direction of the company’s investments, fostering growth, and integrating emerging tech solutions to enhance the core operations of the CME Group. His contributions are vital for maintaining the competitive edge and technological advancement of the CME Group in the global market.
Mr. John C. Peschier
Managing Director of Investor Relations
John C. Peschier serves as the Managing Director of Investor Relations at CME Group Inc. He plays a crucial role in maintaining the company's relationships with the investment community, providing them with timely and accurate information regarding the company's operations, performance, and strategy. His responsibilities include overseeing the communication of financial results, strategic initiatives, and market developments to investors and analysts. Through this engagement, he helps ensure that CME Group’s valuation reflects its business prospects and achievements. Peschier’s previous experience and financial expertise contribute significantly to his role in aligning investor communications with corporate objectives.
Ms. Anita Liskey
Senior Managing Director of Corporate Marketing & Communications
Anita Liskey serves as the Managing Director of Corporate Marketing and Communications at CME Group Inc. In her role, she is responsible for overseeing all aspects of the company’s marketing, brand management, external and internal communications, and corporate citizenship efforts. Liskey plays a crucial part in shaping CME Group's strategic messaging and enhancing its global presence through effective communication strategies. She has been with CME Group for an extended period, contributing her extensive experience in marketing and communications to the financial services sector. Her leadership helps in promoting the company's brand and ensuring coherent communication across various platforms.
Ms. Hilda Harris Piell
Senior MD & Chief Human Resources Officer
Hilda Harris Piell is a senior executive at CME Group Inc., holding the position of Managing Director and Chief Human Resources Officer. She plays a critical role in overseeing the global human resources strategies and initiatives for the firm. Her responsibilities typically include talent acquisition and management, leadership development, employee engagement, and organizational culture. Hilda is known for her strategic leadership in aligning HR practices with the overall business goals of CME Group. Her experience and insights help drive the company's efforts to maintain a diverse and effective workforce. Prior to her role at CME Group, she has held various HR-related positions that have equipped her with a wealth of experience in the field.
Mr. Kendal Vroman
Chief Transformation Officer
Kendal Vroman is a notable executive at CME Group Inc., where he serves as the Chief Corporate Development Officer. In this role, he is responsible for leading strategic initiatives, acquisitions, and partnerships that contribute to the growth and expansion of the company's market position. Vroman plays a crucial role in exploring and executing new business opportunities, ensuring that CME Group continues to adapt and thrive in the rapidly evolving financial markets landscape. His expertise in strategy and development, along with his leadership skills, have made him a key figure in driving the company's long-term growth objectives.
Mr. Richard Romeo
Managing Director of Financial Planning & Analysis
Richard Romeo is the Chief Technology Officer (CTO) at CME Group Inc., a leading global derivatives marketplace. With extensive experience in information technology and financial services, Romeo is responsible for overseeing the enterprise technology strategy and ensuring the company’s systems are robust, secure, and innovative. He has played a significant role in advancing CME Group's technological initiatives, particularly in enhancing trading platforms, cybersecurity, and data analytics capabilities. His leadership contributes to the firm's ability to efficiently handle large volumes of transactions and stay competitive in the fast-paced financial markets. Romeo's career at CME Group and his contributions have been instrumental in maintaining the organization's position as a forefront leader in the global financial sector.
1 / 10
Mr. Sunil Cutinho
Chief Information Officer
Sunil Cutinho serves as the President of CME Clearing, a division of CME Group Inc. In this role, he is responsible for overseeing the risk management and clearing functions, ensuring the safeguarding and management of collateral as well as guaranteeing the integrity and financial stability of the marketplace. His leadership is critical in managing counterparty risk and protecting market participants in CME Group's clearing operations.
Before assuming the President position, Cutinho held several other roles at CME Group, where he contributed significantly to technological and clearing services advancements. His background includes extensive experience in technology and operations within financial services, having led the transformation and innovation in risk management and settlement processes.
Cutinho's leadership and expertise have been vital in guiding CME Clearing through changes in regulatory landscapes and in adapting to the evolving needs of the market. His work ensures that the clearing operations remain efficient, reliable, and secure, providing the foundation for one of the world's leading derivatives marketplaces.
Mr. Derek Sammann
Senior MD & Global Head of Commodities Markets
Derek Sammann is a prominent figure in the global derivatives market, known for his role at CME Group Inc., where he has made significant contributions. At CME Group, Derek Sammann serves as the Senior Managing Director and Global Head of Commodities, Options, and International Markets. In this capacity, he is responsible for the strategic leadership and growth of CME Group's options and commodity product lines, as well as the company's international business development efforts.
Derek Sammann joined CME Group in 2006, bringing with him extensive experience in the industry, having held various leadership positions focused on trading, risk management, and the expansion of global markets. His unique expertise has been instrumental in driving innovation and expansion within the CME Group's diverse portfolio of products.
Under his leadership, the company has seen significant advancements in the trading of options and commodities, bolstering CME Group's position as a leader in the global derivatives marketplace. Sammann's vision and strategic direction have also been pivotal in fostering international relationships and expanding CME Group's footprint in key global markets.
His work is characterized by a deep understanding of the complexities of derivatives trading and a commitment to advancing CME Group's reach and influence across the globe. Derek Sammann is recognized for his strategic insight, leadership, and dedication to the growth and development of CME Group within the international financial landscape.
Mr. Michael G. Dennis
Global Head of Fixed Income
Michael G. Dennis serves as the Managing Director and Chief Corporate Development Officer at CME Group Inc. In this capacity, he plays a pivotal role in shaping the strategic direction of the company. His responsibilities primarily include leading mergers, acquisitions, and other strategic initiatives that are essential for the growth and expansion of CME Group in the global financial markets. Dennis is instrumental in identifying new opportunities and partnerships that align with the company's long-term objectives.
With an extensive background in corporate development, Dennis has been a key figure in executing transformative transactions that enhance the company’s competitive position. Prior to his current role, he gained considerable experience in investment banking and financial services, which equipped him with the skills necessary to navigate the complex financial landscape. He is recognized for his strategic vision, leadership, and ability to drive value creation for the organization.
Michael G. Dennis's contributions continue to be significant as he guides CME Group through evolving market dynamics and positions the company for sustained success in the industry.
Ms. Suzanne Sprague
Senior MD, COO & Global Head of Clearing
Suzanne Sprague is a notable executive at CME Group Inc., where she plays an important role in the company’s operations within its clearing and risk management functions. Generally, her responsibilities at CME Group may include overseeing the development and implementation of risk management strategies, ensuring the integrity and security of financial transactions processed through the exchange, and contributing to the strategic initiatives of the company.
Her leadership and expertise in risk management and clearing services have been instrumental in maintaining CME Group's reputation as a leading global derivatives marketplace. Ms. Sprague's work supports the seamless functioning of futures and options trading, ensuring a robust framework for risk assessment and mitigation.
Suzanne Sprague's contributions to the company have likely involved collaboration with regulatory bodies, continuous enhancement of risk management tools, and possibly innovations that drive growth and operational efficiency. Her role underscores CME Group's commitment to providing secure and reliable financial markets.
Mr. Jack Tobin
MD & Chief Accounting Officer
Jack Tobin serves as the Managing Director and Chief Executive Officer of CME Ventures, a subsidiary of the CME Group. In this role, he is responsible for overseeing venture capital investments and strategic initiatives. His work involves identifying innovative technologies and startups that align with the broader goals of the CME Group, which is a leading global derivatives marketplace.
Tobin has a strong background in financial services and technology, contributing to his effective leadership at CME Ventures. His experiences and leadership skills play a significant role in guiding the strategic direction of the company’s investments, fostering growth, and integrating emerging tech solutions to enhance the core operations of the CME Group. His contributions are vital for maintaining the competitive edge and technological advancement of the CME Group in the global market.
Mr. John C. Peschier
Managing Director of Investor Relations
John C. Peschier serves as the Managing Director of Investor Relations at CME Group Inc. He plays a crucial role in maintaining the company's relationships with the investment community, providing them with timely and accurate information regarding the company's operations, performance, and strategy. His responsibilities include overseeing the communication of financial results, strategic initiatives, and market developments to investors and analysts. Through this engagement, he helps ensure that CME Group’s valuation reflects its business prospects and achievements. Peschier’s previous experience and financial expertise contribute significantly to his role in aligning investor communications with corporate objectives.
Ms. Anita Liskey
Senior Managing Director of Corporate Marketing & Communications
Anita Liskey serves as the Managing Director of Corporate Marketing and Communications at CME Group Inc. In her role, she is responsible for overseeing all aspects of the company’s marketing, brand management, external and internal communications, and corporate citizenship efforts. Liskey plays a crucial part in shaping CME Group's strategic messaging and enhancing its global presence through effective communication strategies. She has been with CME Group for an extended period, contributing her extensive experience in marketing and communications to the financial services sector. Her leadership helps in promoting the company's brand and ensuring coherent communication across various platforms.
Ms. Hilda Harris Piell
Senior MD & Chief Human Resources Officer
Hilda Harris Piell is a senior executive at CME Group Inc., holding the position of Managing Director and Chief Human Resources Officer. She plays a critical role in overseeing the global human resources strategies and initiatives for the firm. Her responsibilities typically include talent acquisition and management, leadership development, employee engagement, and organizational culture. Hilda is known for her strategic leadership in aligning HR practices with the overall business goals of CME Group. Her experience and insights help drive the company's efforts to maintain a diverse and effective workforce. Prior to her role at CME Group, she has held various HR-related positions that have equipped her with a wealth of experience in the field.
Mr. Kendal Vroman
Chief Transformation Officer
Kendal Vroman is a notable executive at CME Group Inc., where he serves as the Chief Corporate Development Officer. In this role, he is responsible for leading strategic initiatives, acquisitions, and partnerships that contribute to the growth and expansion of the company's market position. Vroman plays a crucial role in exploring and executing new business opportunities, ensuring that CME Group continues to adapt and thrive in the rapidly evolving financial markets landscape. His expertise in strategy and development, along with his leadership skills, have made him a key figure in driving the company's long-term growth objectives.
Mr. Richard Romeo
Managing Director of Financial Planning & Analysis
Richard Romeo is the Chief Technology Officer (CTO) at CME Group Inc., a leading global derivatives marketplace. With extensive experience in information technology and financial services, Romeo is responsible for overseeing the enterprise technology strategy and ensuring the company’s systems are robust, secure, and innovative. He has played a significant role in advancing CME Group's technological initiatives, particularly in enhancing trading platforms, cybersecurity, and data analytics capabilities. His leadership contributes to the firm's ability to efficiently handle large volumes of transactions and stay competitive in the fast-paced financial markets. Romeo's career at CME Group and his contributions have been instrumental in maintaining the organization's position as a forefront leader in the global financial sector.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
